【摘 要】
:
Introduction: To compare definitive intensity-modulated radiotherapy (IMRT) with definitive 2D radiotherapy (2D-RT) in cervical esophageal squamous cell carcinoma (CESCC).Methods: A total of 101 patie
【机 构】
:
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union
论文部分内容阅读
Introduction: To compare definitive intensity-modulated radiotherapy (IMRT) with definitive 2D radiotherapy (2D-RT) in cervical esophageal squamous cell carcinoma (CESCC).Methods: A total of 101 patients with CESCC treated with definitive radiotherapy during January 2001 through April 2012 were analyzed.Thirty-seven patients were irradiated using 2D-RT, whereas 64 cases were treated using IMRT.Results: The median follow-up time was 15.5 months for all the patients.For all patients, the overall 2-year local failure-free survival(LFFS), regional failure-free survival(RFFS), and overall survival(OS) rate was 67.4%, 85.2% and 46.2%, respectively.The 2-year LFFS rate and the 2-year RFFS rate in the IMRT group were higher than the 2D-RT group, although no statistically significant difference was observed in LFFS and RFFS.No statistically significant difference was observed in OS between the groups.Compared with 2D-RT, the rate of severe dysphagia after radiotherapy was lower (6.3% vs.8.1%) and none had hypothyroidism requiring lifelong thyroxine replacement in the IMRT group.Matched cases analysis did not show a statistical difference in terms of LFFS, RFFS and OS between the groups.Conclusions: Although no statistically significant difference was observed in OS, LFFS and RFFS between the IMRT group and the 2D-RT group, the incidence of late toxicity had declined by using IMRT, thereby resulting in an improved therapeutic ratio for patients with CESCC.
其他文献
目的:探讨结核菌素试验(PPD)和T-SPOT对结核病患者的临床诊断价值。方法:对本院2011年1月至11月收治的222例结核病患者进行PPD试验和外周血T-SPOT检测,并分析其结果。结果:222例结核病患者中,PPD阳性者139例,PPD的阳性率为62.6%(139/222),T-SPOT阳性者192例,T-SPOT的阳性率为86.5% (192/222),两种阳性率经过统计学处理差异具有显著
目的:探讨青春期白血病患儿疾病信息需求,为给患儿提供恰当的疾病信息提供指导.方法:采用质性研究中的个体化深入访谈法,以20例青春期白血病患儿作为研究对象,应用半结构式的开放性访谈问卷收集资料,使用内容分析法分析资料.结果:青春期白血病患儿疾病信息需求,在疾病内容方面主要有——疾病早期:疾病诊断,治疗效果,疾病原因,饮食指导,治疗所需时间,疾病对远期生活的影响;疾病中期:药物方面的知识,主要化验检查
目的:探讨门诊中心治疗室差错事故发生的相关性及改进方法.方法:通过SHEL方法分析总结135例差错事故及改进措施,完善各个环节的服务流程.结果:通过具体改进措施,有效杜绝工作中的差错事故,零发生无投诉,患者满意度提高.结论:通过门诊中心治疗室差错相关性分析,及时改进工作中存在的弊端,细化流程,加强护理管理,提高优质护理服务水平,最终提升医院的护理管理品质.
目的:探讨健康教育减轻慢性阻塞性疾病患者家属焦虑的效果.方法:将符合慢性阻塞性肺疾病诊断标准的病人的家属271例,随机分为健康教育组141例,对照组130例,在入院时进行SAS量表评分.护士按医院例行方式与对照组家属接触,健康教育组则由护士给予慢性阻塞性肺疾病的相关知识、家庭护理常识等健康教育,出院前对两组家属再次进行SAS评分.结果:健康教育组出院前焦虑程度明显低于对照组(P<0.01);文化水
Introduction: Stereotactic body radiation therapy (SBRT) and Radiofrequency ablation (RFA) are two important treatment options for medically inoperable patients with stage Ⅰ non-small cell lung cancer
目的:了解中国乳腺癌术后放疗的变化,为改进治疗方式提供依据.方法:随机纳入国内不同地理区域的7家医院在1999-2008年收治的乳腺癌病人.每年随机选出一个月代表每家医院的这一年,对选定月份的所有住院乳腺癌病例进行分析.随机入选病例占7家医院10年间收治乳腺癌的9.3% (4211/45200).本研究分析根治术后和保乳术后放疗的使用情况,放疗部位的变化情况.统计学分析采用Cochran-Armi
目的:回顾性分析乳腺癌脑转移再程放疗的疗效和影响预后的相关因素.方法:收集36例行再程放疗的乳腺癌脑转移患者,按L-Q模式计算等效生物剂量,计算总生存时间、中位局部控制时间,评估疗效、记录放疗不良反应.结果:全组患者中位年龄51.2岁(32.2-64.8岁),再程放疗后中位生存时间为9.1个月(1.3-56.8个月),6个月、12个月的总生存率分别为71.1%和33.9%,局部控制率分别为72.3
目的:探讨乳腺癌脑转移患者(Breast cancer brain metastases BCBM)预后生存的影响因素.方法:回顾分析2000年1月至2013年8月军事医学科学院附属医院收治的342例乳腺癌脑转移患者的临床病理资料、治疗措施等因素对BCBM患者生存期的影响.结果:全组患者脑转移的中位年龄47.8岁(25.3-79.9岁),从确诊乳腺癌到发生脑转移的中位时间为40.5个月(0-264